Intravenously administered recombinant tissue-plasminogen activator attenuates neuronal injury after mild focal cerebral ischemia in mice

NeuroReport

Volumn 15, Issue 4, 2004, Pages 687-689

  Kilic, Ertugrul ^a   Kilic, Ülkan ^a   Bassetti, Claudio L ^a   Hermann, Dirk M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Caspase 3 activity; Hemodynamic; Intraluminal thread occlusion; Serine protease; Thrombolytic

Indexed keywords

ALTEPLASE; CASPASE 3; CRESYL VIOLET; DYE; IODOPHENAZONE C 14; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN ISCHEMIA; BRAIN PERFUSION; CONTROLLED STUDY; CORPUS STRIATUM; HISTOPATHOLOGY; IMMUNOCYTOCHEMISTRY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NERVE CELL NECROSIS; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; CASPASE 3; CASPASES; CELL COUNT; CELL SURVIVAL; CEREBRAL INFARCTION; CEREBROVASCULAR CIRCULATION; CORPUS STRIATUM; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; INJECTIONS, INTRAVENOUS; ISCHEMIC ATTACK, TRANSIENT; LASER-DOPPLER FLOWMETRY; MALE; MICE; MICE, INBRED C57BL; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; RECOMBINANT FUSION PROTEINS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 1842504075     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-200403220-00022     Document Type: Article

References (9)

1. Wang YF, Tsirka SE, Strickland S, Stieg PE, Soriano SG and Lipton SA. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-defident mice. Nature Med 4, 228-231 (1998).
2. Kilic E, Bähr M and Hermann DM. Effects of recombinant tissue plasminogen activator after intraluminal thread occlusion in mice. Stroke 32, 2641-2647 (2001).
3. Hermann DM, Kilic E, Hata R, Mies G and Hossmann KA. Relationship between metabolic changes, gene responses and delayed ischemic injury after mild focal cerebral ischemia in mice. Neuroscience 104, 947-955 (2001).
4. Hermann DM, Kilic E, Kügler S, Isenmann S and Bähr M. Adenovirus-mediated GDNF and CNTF pretreatment protects against striatal injury following transient middle cerebral artery occlusion in mice. Neurobiol Dis 8, 655-666 (2001).
5. Traynelis SF and Lipton SA. Is tissue plasminogen activator a threat to neurons? Nature Med 7, 17-18 (2001).
6. L is protective after middle cerebral artery occlusion in mice. Ann Neurol 52, 617-622 (2002).
7. Nicole O, Docagne F, Ali C, Margaill I, Carmeliet P, MacKenzie ET, Vivien D and Buisson A. The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling. Nature Med 7, 59-64 (2001).
8. Zhang Z, Zhang L, Yepes M, Jiang Q, Li Q, Arniego P et al. Adjuvant treatment with neuroserpin increases the therapeutic window for tissue-type plasminogen activator administration in a rat model of embolic stroke. Circulation 106, 740-745 (2002).
9. Buisson A, Lesne S, Docagne F, Ali C, Nicole O, MacKenzie ET and Vivien D. Transforming growth factor-beta and ischemic brain injury. Cell Mol Neurobiol 23, 539-550 (2003).